Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements

作者：Stacie B. Dusetzina, Grace Castle, Jihye Han, Ashley A. Leech, Jinyi Zhu · 发表于：JAMA · 年份：2026 · DOI：10.1001/jama.2026.2615 · 被引用次数：3 · 研究领域：Medication Adherence and Compliance、Diabetes Treatment and Management、Health Systems, Economic Evaluations, Quality of Life

This study compares expected total Medicare spending on semaglutide in 2027 under voluntary price agreement participation vs nonparticipation and estimates beneficiaries eligible for expanded obesity-indication coverage whose treatment costs could be offset with savings from the agreement.